Emergency department staff and susceptibility to pertussis: A seroprevalence study

EMA - Emergency Medicine Australasia

Volumn 20, Issue 1, 2008, Pages 45-50

  Faruque, M Omar ^a   Senanayake, Sanjaya ^b   Meyer, Alastair D McR ^d   Dear, Keith B G ^c  

^a ST GEORGE HOSPITAL   (Australia)

^b CANBERRA HOSPITAL   (Australia)

^c The Australian National University   (Australia)

^d Casey Hospital   (Australia)

Author keywords

Emergency department; Hospital; Immunization; Pertussis; Serology; Vaccination

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS VACCINE;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD SAMPLING; BORDETELLA PERTUSSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HUMAN; IMMUNIZATION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; PERTUSSIS; PRIORITY JOURNAL; PRIVATE HOSPITAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SEROPREVALENCE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; PERSONNEL, HOSPITAL; PERTUSSIS VACCINE; SEROEPIDEMIOLOGIC STUDIES; TASMANIA; WHOOPING COUGH;

EID: 38849101601     PISSN: 17426731     EISSN: 17426723     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2007.01044.x     Document Type: Article

References (33)

1. Guiso N. Why still whooping cough? Rev. Prat. 2005 55 : 1287 92.
2. Levy J, Swennen B, Van Laethem Y. Pertussis vaccine in adolescents and adults. Rev. Med. Brux. 2004 25 : A229 32.
3. Galanis E, King AS, Varughese P, Halperin SA. Changing epidemiology and emerging risk groups for pertussis. CMAJ 2006 174 : 451 2.
4. Storsaeter J, Wolter J. Is there a need for a new generation of vaccines against pertussis? Expert Opin. Emerg. Drugs 2006 11 : 195 205.
5. Bass JW, Wittler RR. Return of epidemic pertussis in the United States. Pediatr. Infect. Dis. J. 1994 13 : 343 5.
6. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. Br. Med. J. (Clin. Res. Ed.) 1988 296, 612 14.
7. Centers for Disease Control and Prevention. Pertussis. In : Atkinson W, Hambrosky J, McIntyre L, Wolfe C, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases, 10th edn. Washington DC : Public Health Eoundation, 2007 82 100.
8. Tozzi AE, Rava L, Ciofi degli Atti ML, Salmaso S. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 2003 112 : 1069 75.
9. Black S. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 1997 16 : S85 9.
10. Cromer BA, Goydos J, Hackell J, Mezzatesta J, Dekker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am. J. Dis. Child. 1993 147 : 575 7.
11. Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: a cause of persistent cough in adults. Med. J. Aust. 1987 146 : 522 5.
12. Centre for Disease Control and Prevention. Pertussis outbreaks - Massachusetts and Maryland, 1992. MMWR Morb. Mortal. Wkly. Rep. 1993 42 : 197 200.
13. He Q, Viljanen MK, Nikkari S, Lyytikainen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J. Infect. Dis. 1994 170 : 873 7.
14. WHO. Pertussis vaccines - WHO position paper. Wkly. Epidemiol. Rec. 2005 80 : 31 9.
15. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect. Dis. 2002 2 : 744 50.
16. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005 18 : 326 82.
17. Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am. J. Dis. Child. 1978 132 : 371 3.
18. Mertsola J, Ruuskanen O, Eerola E, Viljanen MK. Intrafamilial spread of pertussis. J. Pediatr. 1983 103 : 359 63.
19. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J. Infect. Dis. 1990 161 : 480 86.
20. Izurieta HS, Kenyon TA, Strebel PM, Baughman AL, Shulman ST, Wharton M. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin. Infect. Dis. 1996 22 : 503 7.
21. National Notifiable Diseases Surveillance System [homepage on the Internet]. Canberra, Australia. [Cited 30 August 2006.] Available from URL: http://www.dhac.gov.au/internet/wcms/publishing.nsf/Content/ Nationally+notifiable+diseases+%28NNDSS%29-1
22. Nouvellon M, Gehanno JF, Pestel Caron M, Weber C, Lemeland JF, Guiso N. Usefulness of pulsed-field gel electrophoresis in assessing nosocomial transmission of pertussis. Infect. Control Hosp. Epidemiol. 1999 20 : 758 60.
23. Tanaka Y, Fujinaga K, Goto A, et al. Outbreak of pertussis in a residential facility for handicapped people. Dev. Biol. Stand. 1991 73 : 329 32.
24. Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am. J. Dis. Child. 1980 134 : 520 21.
25. Kurt TL, Yeager AS, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972 221 : 264 7.
26. de Juanes JR, Gil A, Gonzalez A, Arrazola MP, San-Martin M, Esteban J. Seroprevalence of pertussis antibody among health care personnel in Spain. Eur. J. Epidemiol. 2004 19 : 69 72.
27. The Australian Immunisation Handbook, 8th edn. Canberra : National Health & Medical Research Council, 2003.
28. Ruuskanen O, Noel A, Putto-Laurila A, et al. Development of an acellular pertussis vaccine and its administration as a booster in healthy adults. Vaccine 1991 9 : 117 21.
29. Edwards KM, Decker MD, Graham BS, Mezzatesta J, Scott J, Hackell J. Adult immunization with acellular pertussis vaccine. JAMA 1993 269 : 53 6.
30. Kanra G, Ceyhan M, Vandevoorde D, Bogaerts H. Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane proteins as a booster in children. Eur. J. Pediatr. 1993 152 : 478 83.
31. Englund JA, Decker MD, Edwards KM, Pichichero ME, Steinhoff MC, Anderson EL. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Pediatrics 1994 93 : 37 43.
32. Tinnion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst. Rev. 2000 CD001478.
33. Halperin SA, Sweet L, Baxendale D, et al. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Pediatr. Infect. Dis. J. 2006 25 : 195 200.